Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Natural toxins (Print)

• Publication date

  1999-11-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0PMID 11122537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues.

  2006cited by this paper
• Screening of fungal species for fumonisin production andfumonisin-like disruption of sphingolipid biosynthesis

  2004cited by this paper
• Fermentation, partial purification, and use of serine palmitoyltransferase inhibitors from Isaria (= Cordyceps) sinclairii.

  2000cited by this paper
• Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.

  1999cited by this paper
• Quantitative analysis of free sphingoid bases in the brain and spinal cord tissues by high-performance liquid chromatography with a fluorescence detection.

  1998cited by this paper
• Liquid chromatographic determination of the sphinganine/sphingosine ratio in serum.

  1998cited by this paper
• Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure.

  1998cited by this paper
• Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure.

  1997cited by this paper
• Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.

  1997cited by this paper
• A rapid method for quantifying free sphingoid bases and complex sphingolipids in microgram amounts of cells following exposure to fumonisin B(1).

  1996cited by this paper
• Time- and dose-response effects of the mycotoxin, fumonisin B(1) on sphingoid base elevations in precision-cut rat liver and kidney slices.

  1996cited by this paper
• Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.

  1996cited by this paper
• Liquid chromatographic determination of sphinganine and sphingosine : use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins

  1994cited by this paper
• Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.

  1994cited by this paper
• Fumonisin- and AAL-Toxin-Induced Disruption of Sphingolipid Metabolism with Accumulation of Free Sphingoid Bases

  1994cited by this paper
• Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.

  1993cited by this paper
• Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.

  1992cited by this paper
• Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

  1991cited by this paper
• Quantitation of free sphingosine in liver by high-performance liquid chromatography.

  1988cited by this paper
• A stereoselective synthesis of sphingosine, a protein kinase c inhibitor

  1988cited by this paper

• Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer

  2021cites this paper
• Approaches for probing and evaluating mammalian sphingolipid metabolism.

  2019cites this paper
• Quantification of 3-ketodihydrosphingosine using HPLC-ESI-MS/MS to study SPT activity in yeast Saccharomyces cerevisiae[S]

  2017cites this paper
• Abbreviations: alkyne-doxSA: (2S,3R)-2-aminooctadec-17-yn-3-ol; alkyne-SA: (2S,3R)-2- aminooctadec-17-yn-1,3-diol; ASTM-BODIPY: azido-sulfo-tetramethyl-BODIPY; CE: cholesterolester; Cer: ceramide; CerS: ceramide synthase; DHCer; dihydroceramide; deoxySLs: 1-deoxysphingolipids; doxCer: 1-deoxyceramid

  2016cites this paper
• Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway[S]

  2016cites this paper
• Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction[S]

  2016cites this paper
• Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

  2012cites this paper
• Terpene Alcohols Inhibit De Novo Sphingolipid Biosynthesis

  2012cites this paper
• MUTATIONS IN SPTLC 2 GENE ASSOCIATED WITH SENSORY NEUROPATHY FIELD OF THE

  2012cites this paper
• Chapter 6 – Ceramides

  2012cites this paper
• Terpene alcohols inhibit de novo sphingolipid biosynthesis.

  2012cites this paper
• Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I

  2011cites this paper
• Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I.

  2010cites this paper
• Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦

  2010cites this paper
• A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated

  2009cites this paper
• The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases*

  2009cites this paper
• Overexpression of the Wild-Type SPT1 Subunit Lowers Desoxysphingolipid Levels and Rescues the Phenotype of HSAN1

  2009cites this paper
• Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine

  2009cites this paper
• Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects.

  2009cites this paper
• Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development

  2008cites this paper
• Use of Formalin-Fixed Tissues to Determine Fumonisin B1-Induced Sphingolipid Alterations in Swine

  2007cites this paper
• Ceramide and other sphingolipids in cellular responses

  2007cites this paper
• The role of tumor necrosis factor alpha and the peroxisome proliferator-activated receptor alpha in modulating the effects of fumonisin in mouse liver.

  2006cites this paper
• The role of tumor necrosis factor α and the peroxisome proliferator-activated receptor α in modulating the effects of fumonisin in mouse liver

  2006cites this paper
• Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.

  2005cites this paper
• Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.

  2005influential citation
• Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.

  2005cites this paper
• Efficacy of a commercial mycotoxin binder in alleviating effects of ochratoxin A, fumonisin B1, moniliformin and zearalenone in adult mink.

  2004cites this paper
• Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert.

  2004cites this paper
• Fumonisin-ortho-phthalaldehyde derivative is stabilized at low temperature.

  2004cites this paper
• The effects of fumonisin B1 toxicity upon neuronal tissue

  2004cites this paper
• Glucose reaction with fumonisin B1 partially reduces its toxicity in swine.

  2004cites this paper
• Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.

  2003cites this paper
• Nutrient Interactions and Toxicity Research Communication Total Fumonisins Are Reduced in Tortillas Using the Traditional Nixtamalization Method of Mayan Communities

  2003cites this paper
• Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.

  2002cites this paper
• Paradoxical role of tumor necrosis factor alpha in fumonisin-induced hepatotoxicity in mice.

  2002cites this paper
• Paradoxical role of tumor necrosis factor α in fumonisin-induced hepatotoxicity in mice

  2002cites this paper
• Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.

  2001cites this paper